The Current Ratio as of September 2024 (TTM) for Harmony Biosciences Holdings, Inc. (HRMY) is 3.13

According to Harmony Biosciences Holdings, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.13. This represents a change of -4.58% compared to the average of 3.28 of the last 4 quarters.

Harmony Biosciences Holdings, Inc. (HRMY) Historical Current Ratio (quarterly & annually)

How has HRMY Current Ratio performed in the past?

The mean historical Current Ratio of Harmony Biosciences Holdings, Inc. over the last ten years is 4.77. The current 3.13 Current Ratio has changed 6.45% with respect to the historical average. Over the past ten years (40 quarters), HRMY's Current Ratio was at its highest in in the September 2020 quarter at 7.87. The Current Ratio was at its lowest in in the March 2019 quarter at 0.

Harmony Biosciences Holdings, Inc. (HRMY) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Harmony Biosciences Holdings, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Harmony Biosciences Holdings, Inc. (HRMY) Average Current Ratio

How has HRMY Current Ratio performed in the past?

The current Current Ratio of Harmony Biosciences Holdings, Inc. (HRMY) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Harmony Biosciences Holdings, Inc. (HRMY) Current Ratio vs. Peers

How is HRMY’s Current Ratio compared to its peers?

Harmony Biosciences Holdings, Inc.’s Current Ratio is less than Keros Therapeutics, Inc. (20.37), less than Janux Therapeutics, Inc. (57.34), less than Fennec Pharmaceuticals Inc. (8.02), less than Edgewise Therapeutics, Inc. (30.24), less than Pliant Therapeutics, Inc. (14.47), less than Syndax Pharmaceuticals, Inc. (10.50), less than Revolution Medicines, Inc. (15.42), less than Viridian Therapeutics, Inc. (15.82), less than Inozyme Pharma, Inc. (9.84), less than Ventyx Biosciences, Inc. (14.19), less than Nuvalent, Inc. (17.44), less than Cerevel Therapeutics Holdings, Inc. (10.22), greater than Travere Therapeutics, Inc. (3.04), less than Structure Therapeutics Inc. (41.38), less than Replimune Group, Inc. (13.46), less than Nuvectis Pharma, Inc. (3.17), less than Lyra Therapeutics, Inc. (3.60), less than Kronos Bio, Inc. (8.49), less than Gossamer Bio, Inc. (8.21), less than IDEAYA Biosciences, Inc. (17.50), less than Protagonist Therapeutics, Inc. (13.73), less than Verona Pharma plc (8.61),

Build a custom stock screener for Harmony Biosciences Holdings, Inc. (HRMY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Harmony Biosciences Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Harmony Biosciences Holdings, Inc. (HRMY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Harmony Biosciences Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.